Human macrophages and dendritic cells can equally present MART-1 antigen to CD8(+) T cells after phagocytosis of gamma-irradiated melanoma cells.
Dendritic cells (DC) can achieve cross-presentation of naturally-occurring tumor-associated antigens after phagocytosis and processing of dying tumor cells. They have been used in different clinical settings to vaccinate cancer patients. We have previously used gamma-irradiated MART-1 expressing mel...
Main Authors: | María Marcela Barrio, Riad Abes, Marina Colombo, Gabriela Pizzurro, Charlotte Boix, María Paula Roberti, Emmanuelle Gélizé, Mariana Rodriguez-Zubieta, José Mordoh, Jean-Luc Teillaud |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3388056?pdf=render |
Similar Items
-
Dendritic cell-based vaccine efficacy: aiming for hot spots
by: Gabriela Andrea Pizzurro, et al.
Published: (2015-03-01) -
Impact of Glycosylation on Effector Functions of Therapeutic IgG
by: Jean-Luc Teillaud, et al.
Published: (2010-01-01) -
Dendritic Cell-Mediated Phagocytosis but Not Immune Activation Is Enhanced by Plasmin.
by: Rachael J Borg, et al.
Published: (2015-01-01) -
Monocyte-derived dendritic cells loaded with a mixture of apoptotic/necrotic melanoma cells efficiently cross-present gp100 and MART-1 antigens to specific CD8<sup>+ </sup>T lymphocytes
by: Li Yongqing, et al.
Published: (2007-04-01) -
Poly(ethylene glycol)-Lipid-Conjugated Antibodies Enhance Dendritic Cell Phagocytosis of Apoptotic Cancer Cells
by: Teruyuki Nagamune, et al.
Published: (2012-04-01)